Ran Xue
Capital Medical University
21 Papers
24 Citations
Ran Xue is an academic researcher from Capital Medical University. The author has contributed to research in topics: Medicine & Protein kinase B. The author has an hindex of 9, co-authored 13 publications.
Chat about Author
Papers
A Rising Star in Pancreatic Diseases: Pancreatic Stellate Cells
TL;DR: This paper systematically summarizes the recent researches about the biological behaviors of PSC, including its stem/progenitor cell characteristics, secreted exosomes, cellular senescence, epithelial mesenchymal transformation (EMT), energy metabolism and direct mechanical reprogramming.
Coenzyme Q10 inhibits the activation of pancreatic stellate cells through PI3K/AKT/mTOR signaling pathway.
TL;DR: The finding suggests that CoQ10 inhibits the activation of PSCs by suppressing autophagy through activating the PI3K/AKT/mTOR signaling pathway and may act as a therapeutic agent in PSC-relating pathologies and/or anti-fibrotic approaches.
Nrf2-Mediated Ferroptosis Inhibition Exerts a Protective Effect on Acute-on-Chronic Liver Failure
TL;DR: In this article , the liver tissues of acute-on-chronic liver failure (ACLF) patients were collected and murine models of ACLF using carbon tetrachloride, D-galactosamine, and lipopolysaccharide as well as an H2O2-induced hepatocyte injury model were established.
The significance of glypican-3 expression profiling in the tumor cellular origin theoretical system for hepatocellular carcinoma progression.
Ran Xue,Jiliang Feng,Qinghua Meng,Fudong Lv,Yueke Zhu,Hongwei Yu,Shi-Jie Zhang,Chenzhao Song,Lin Sun,Zhujun Yue,Shuai Feng,Ruiwen Che,Qian Xiang,Xiaodan Jing +13 more
TL;DR: The aim was to investigate the dynamic expression of GPC3 during tumor cells differentiation and to explore the role and theoretical significance of G PC3 in malignant essence of HCC.
27
Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma.
Qinwei Yao,Xuli Bao,Ran Xue,Hui Liu,Haixia Liu,Juan Li,Jinling Dong,Zhong-Hui Duan,Meixin Ren,Juan Zhao,Qi Song,Hongwei Yu,Yueke Zhu,Jun Lu,Qinghua Meng +14 more
TL;DR: It was shown that the immunoscore staging system can compensate the TNM tumor classification system in predicting the prognosis of HBV-HCC patients.
24